A detailed history of Investors Research Corp transactions in Elevance Health, Inc. stock. As of the latest transaction made, Investors Research Corp holds 235 shares of ELV stock, worth $94,599. This represents 0.03% of its overall portfolio holdings.

Number of Shares
235
Previous 235 -0.0%
Holding current value
$94,599
Previous $127,000 3.94%
% of portfolio
0.03%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$464.61 - $519.96 $18,119 - $20,278
-39 Reduced 14.23%
235 $121,000
Q4 2023

Jan 30, 2024

BUY
$433.51 - $488.06 $16,906 - $19,034
39 Added 16.6%
274 $129,000
Q1 2021

Apr 28, 2021

SELL
$287.7 - $371.31 $64,732 - $83,544
-225 Reduced 48.91%
235 $84,000
Q1 2019

Apr 23, 2019

BUY
$248.42 - $317.42 $114,273 - $146,013
460 New
460 $132,000
Q1 2018

May 09, 2018

SELL
$215.63 - $258.19 $194,929 - $233,403
-904 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$183.76 - $234.96 $166,119 - $212,403
904
904 $203,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $96.6B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Investors Research Corp Portfolio

Follow Investors Research Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.